About This Source - RT
The video item below is a piece of English language content from RT (formerly Russia Today). RT is a Russian state-funded broadcaster.
Recent from RT:
RT published this video item, entitled “‘People deserve to have a choice’ | Russia ‘open’ to supplying Sputnik V to EU” – below is their description.
Russia is ready to supply European nations with its Sputnik V jab as it believes people “deserve” to have a choice of vaccines but it is up to the EU to allow it, said Kirill Dmitriev, CEO of the Russian Direct Investment Fund.
Read more: https://on.rt.com/b335
Follow us on Telegram https://t.me/rtintlRT YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.
In This Story: EU
The European Union (EU) is a political and economic union of 27 member states that are located primarily in Europe. Its members have a combined area of 4,233,255.3 km² and an estimated total population of about 447 million.
7 Recent Items: EU
In This Story: Russia
Russia spans more than one-eighth of the Earth’s inhabited land area, stretching eleven time zones, and bordering 16 sovereign nations. Moscow is the country’s capital.
The Soviet Union was dissolved in 1991 and since 1993 Russia been governed as a federal semi-presidential republic. Russia is a major great power, with the world’s second-most powerful military, and the fourth-highest military expenditure. As a recognised nuclear-weapon state, the country possesses the world’s largest stockpile of nuclear weapons.
3 Recent Items: Russia
In This Story: Sputnik V
Gam-COVID-Vac, trade-named Sputnik V, is a COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology, and registered on 11 August 2020 by the Russian Ministry of Health. It has been approved for distribution in Russia.
The phase III trial for Gam-COVID-Vac was registered on 28 August 2020, and is a randomised, double-blind, placebo-controlled, multi-centre clinical trial involving 40,000 volunteers. The phase III trial is scheduled to run until May 2021.
On 5 December 2020, Russia began mass vaccinations in Moscow, with 70 clinics inoculating those most at risk from the virus. Health workers and teachers were said to have priority in the first mass immunisation programme. People who had received injections in the last 30 days or had respiratory diseases in the previous two weeks were excluded, as well as those with certain chronic illnesses, and pregnant and breastfeeding women.